These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15506359)

  • 21. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
    Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
    Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Questions regarding BNP assays.
    Schwam E
    Ann Emerg Med; 2006 Feb; 47(2):213-4; author reply 214. PubMed ID: 16431242
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognosis assessment in patients with decompensated heart failure. Simple clinical parameters or neurohormonal factors.
    Aronson D; Burger AJ
    Ital Heart J; 2004 Jul; 5(7):494-7. PubMed ID: 15487265
    [No Abstract]   [Full Text] [Related]  

  • 25. Learning to use a biomarker. More about B-type natriuretic peptide.
    Mills RM
    J Am Coll Cardiol; 2008 Jun; 51(24):2336-8. PubMed ID: 18549919
    [No Abstract]   [Full Text] [Related]  

  • 26. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
    Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is B-type natriuretic peptide-guided heart failure management cost-effective?
    Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
    Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [B-type natriuretic peptide--current use in the diagnosis and management of heart failure].
    Müller C; Kuster G; Büttner HJ; Buser P
    Herz; 2003 Aug; 28(5):374-9. PubMed ID: 12928736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.
    Burger MR; Burger AJ
    Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring heart failure with brain natriuretic peptide].
    Sela B
    Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 37. Does bnp testing aid diagnosis of heart failure?
    Drug Ther Bull; 2009 Oct; 47(10):110-3. PubMed ID: 19809084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical uses of brain natriuretic peptide in diagnosing and managing heart failure.
    Anderson KM
    J Am Acad Nurse Pract; 2008 Jun; 20(6):305-10. PubMed ID: 18588657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels.
    Daniels LB; Clopton P; Jiang K; Greenberg B; Maisel AS
    J Card Fail; 2010 Feb; 16(2):93-8. PubMed ID: 20142019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.